RE:RE:RE:RE:Debt-Free CPH: At 1.5 times its 2020 EBITDA And The BuybackTrulance was a huge coo for the company negotiating around Bausch to steal the Canadian rights from a now defunct Synergy Pharma. Bausch then bought out the bankrupt company without the Canadian rights. Along came the new management team at Cipher and somehow bungled up the contract and subsequent lawsuit costing them there entire investment plus cost to be determined at a later date. This alone will cost them there profits for the entire year last year. Add to this there number 1 drug absorica will soon be the LD version owned by Sun Pharma and you can see that starting December revenue will fall off a cliff with only the Canadian version Eupuris to prop up dwindling revenue. What a complete debacle by a bunch of clowns. Just my opinion. Blindsided me when Swapper saw it before me!